P. K. Yip and A. Malaspina, Spinal cord trauma and the molecular point of no return, Mol Neurodegener, vol.7, p.6, 2012.

J. Namiki, A. Kojima, and C. H. Tator, Effect of brain-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 on functional recovery and regeneration after spinal cord injury in adult rats, J Neurotrauma, vol.17, issue.12, pp.1219-1250, 2000.

F. Dittrich, Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons, Exp Neurol, vol.141, issue.2, pp.225-264, 1996.

Q. Yan, The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor, J Neurosci, vol.14, issue.9, pp.5281-91, 1994.

A. Kishino, BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth, Exp Neurol, vol.144, issue.2, pp.273-86, 1997.
DOI : 10.1006/exnr.1996.6367

L. Novikov, L. Novikova, and J. O. Kellerth, Brain-derived neurotrophic factor promotes axonal regeneration and long-term survival of adult rat spinal motoneurons in vivo, Neuroscience, vol.79, issue.3, pp.765-74, 1997.

M. Oudega and T. Hagg, Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord, Brain Res, vol.818, issue.2, pp.431-439, 1999.

L. B. Jakeman, Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury, Exp Neurol, vol.154, issue.1, pp.170-84, 1998.

V. M. Tatard, Pharmacologically active microcarriers: a tool for cell therapy, Biomaterials, vol.26, issue.17, pp.3727-3764, 2005.

C. Musilli, Pharmacologically active microcarriers for endothelial progenitor cell support and survival, Eur J Pharm Biopharm, vol.81, issue.3, pp.609-625, 2012.
DOI : 10.1016/j.ejpb.2012.04.014

C. Penna, Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival, J Cell Mol Med, vol.17, issue.1, pp.192-204, 2013.
DOI : 10.1111/j.1582-4934.2012.01662.x
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1582-4934.2012.01662.x

G. J. Delcroix, The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats, Biomaterials, vol.32, issue.6, pp.1560-73, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00541842

N. Daviaud, Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease, Stem Cells Transl Med, vol.4, issue.6, pp.670-84, 2015.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 120

E. Garbayo, Neuroprotective properties of marrow-isolated adult multilineage-inducible cells in rat hippocampus following global cerebral ischemia are enhanced when complexed to biomimetic microcarriers, J Neurochem, vol.119, issue.5, pp.972-88, 2011.

S. Kandalam, Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement, Biosci Rep, vol.16, 2015.
DOI : 10.1016/j.actbio.2016.11.030
URL : https://hal.archives-ouvertes.fr/inserm-01845036

V. R. Dasari, K. K. Veeravalli, and D. H. Dinh, Mesenchymal stem cells in the treatment of spinal cord injuries: A review, World J Stem Cells, vol.6, issue.2, pp.120-153, 2014.

A. Giuliani, Three years after transplants in human mandibles, histological and in-line holotomography revealed that stem cells regenerated a compact rather than a spongy bone: biological and clinical implications, Stem Cells Transl Med, issue.2, pp.316-340, 2013.

E. Karaoz, Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells, Histochem Cell Biol, vol.136, issue.4, pp.455-73, 2011.

F. M. De-almeida, Human dental pulp cells: a new source of cell therapy in a mouse model of compressive spinal cord injury, J Neurotrauma, vol.28, issue.9, pp.1939-1988, 2011.

J. Bianco, Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?, Cell Mol Life Sci, vol.73, issue.7, pp.1413-1450, 2016.

G. T. Huang, The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering, J Endod, vol.34, issue.6, pp.645-51, 2008.

W. Martens, Dental stem cells and their promising role in neural regeneration: an update, Clin Oral Investig, vol.17, issue.9, pp.1969-83, 2013.

P. De-berdt, Dental Apical Papilla as Therapy for Spinal Cord Injury, J Dent Res, vol.94, issue.11, pp.1575-81, 2015.

L. L. Jones, Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury, J Physiol, issue.533, pp.83-92, 2001.

J. P. Karam, Pharmacologically active microcarriers associated with thermosensitive hydrogel as a growth factor releasing biomimetic 3D scaffold for cardiac tissue-engineering, J Control Release, vol.192, pp.82-94, 2014.

M. Morille, New PLGA-P188-PLGA matrix enhances TGF-beta3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells, J Control Release, vol.170, issue.1, pp.99-110, 2013.

N. B. Ruparel, Characterization of a stem cell of apical papilla cell line: effect of passage on cellular phenotype, J Endod, vol.39, issue.3, pp.357-63, 2013.

J. Vanacker, Hypoxia modulates the differentiation potential of stem cells of the apical papilla, J Endod, vol.40, issue.9, pp.1410-1418, 2014.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 121

J. Schira, Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood, Brain, vol.135, issue.2, pp.431-477, 2012.

A. Des-rieux, Vascular endothelial growth factor-loaded injectable hydrogel enhances plasticity in the injured spinal cord, J Biomed Mater Res A, vol.102, issue.7, pp.2345-55, 2014.

D. M. Basso, M. S. Beattie, and J. C. Bresnahan, A sensitive and reliable locomotor rating scale for open field testing in rats, J Neurotrauma, vol.12, issue.1, pp.1-21, 1995.

R. J. Franklin and C. Ffrench-constant, Remyelination in the CNS: from biology to therapy, Nat Rev Neurosci, vol.9, issue.11, pp.839-55, 2008.

C. P. Hofstetter, Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome, Nat Neurosci, vol.8, issue.3, pp.346-53, 2005.

A. Blesch, P. Lu, and M. H. Tuszynski, Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair, Brain Res Bull, vol.57, issue.6, pp.833-841, 2002.

M. Tsintou, K. Dalamagkas, and A. M. Seifalian, Advances in regenerative therapies for spinal cord injury: a biomaterials approach, Neural Regen Res, vol.10, issue.5, pp.726-768, 2015.

S. Thuret, L. D. Moon, and F. H. Gage, Therapeutic interventions after spinal cord injury, Nat Rev Neurosci, vol.7, issue.8, pp.628-671, 2006.

A. Bakopoulou, Angiogenic Potential and Secretome of Human Apical Papilla Mesenchymal Stem Cells in Various Stress Microenvironments, Stem Cells Dev, vol.24, issue.21, pp.2496-512, 2015.

V. M. Tatard, Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons, Bone, vol.40, issue.2, pp.360-73, 2007.

W. H. Chen, Probing relevant molecules in modulating the neurite outgrowth of hippocampal neurons on substrates of different stiffness, PLoS One, vol.8, issue.12, p.83394, 2013.

B. J. Cummings, Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice, Proc Natl Acad Sci, vol.102, issue.39, pp.14069-74, 2005.

J. F. De-almeida, Stem cells of the apical papilla regulate trigeminal neurite outgrowth and targeting through a BDNF-dependent mechanism, Tissue Eng Part A, vol.20, pp.3089-100, 2014.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 138

B. Greenstein, Color Atlas of Neuroscience, 2000.

M. Baehr and M. Frotscher, Duus' Topical Diagnosis in Neurology, vol.5, 2012.

N. A. Silva, From basics to clinical: a comprehensive review on spinal cord injury, Prog Neurobiol, vol.114, pp.25-57, 2014.

, The Central Nervous System, 2013.

P. K. Yip and A. Malaspina, Spinal cord trauma and the molecular point of no return, Mol Neurodegener, vol.7, p.6, 2012.

L. H. Sekhon and M. G. Fehlings, Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine (Phila Pa 1976), pp.2-12, 1924.

I. Karacan, Traumatic spinal cord injuries in Turkey: a nation-wide epidemiological study, Spinal Cord, vol.38, issue.11, pp.697-701, 2000.

R. A. Cripps, A global map for traumatic spinal cord injury epidemiology: towards a living data repository for injury prevention, Spinal Cord, vol.49, issue.4, pp.493-501, 2011.

A. Singh, Global prevalence and incidence of traumatic spinal cord injury, Clin Epidemiol, vol.6, pp.309-340, 2014.

N. T. North, The psychological effects of spinal cord injury: a review, Spinal Cord, vol.37, issue.10, pp.671-680, 1999.

M. Kreuter, Health and quality of life of persons with spinal cord lesion in Australia and Sweden, Spinal Cord, vol.43, issue.2, pp.123-132, 2005.

A. A. Kawu, A cost analysis of conservative management of spinal cord-injured patients in Nigeria, Spinal Cord, vol.49, issue.11, pp.1134-1141, 2011.

A. Selassie, Y. Cao, and L. L. Saunders, Epidemiology of Traumatic Spinal Cord Injury Among Persons Older Than 21 Years: A Population-Based Study in South Carolina, Top Spinal Cord Inj Rehabil, vol.21, issue.4, pp.333-377, 1998.

L. Manchikanti, Comprehensive review of epidemiology, scope, and impact of spinal pain, Pain Physician, vol.12, issue.4, pp.35-70, 2009.

E. Roth, A controlled study of neuropsychological deficits in acute spinal cord injury patients, Paraplegia, vol.27, issue.6, pp.480-489, 1989.

M. Gill, Psychosocial implications of spinal cord injury, Crit Care Nurs Q, vol.22, issue.2, pp.1-7, 1999.

P. Kennedy and B. A. Rogers, Anxiety and depression after spinal cord injury: a longitudinal analysis, Arch Phys Med Rehabil, vol.81, issue.7, pp.932-939, 2000.

H. W. Bonekat, G. Andersen, and J. Squires, Obstructive disordered breathing during sleep in patients with spinal cord injury, Paraplegia, vol.28, issue.6, pp.392-400, 1990.

A. and B. , Mechanical factors in experimental spinal cord injury, J Am Paraplegia Soc, vol.11, issue.2, pp.26-34, 1988.

M. S. Beattie and J. C. Bresnahan, Cell Death, Repair, and Recovery of Function after Spinal Cord Contusion Injuries in Rats, Neurobiology of spinal cord injury, pp.1-21, 2000.

J. C. Bresnahan, A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device, Exp Neurol, vol.95, issue.3, pp.548-70, 1987.

D. H. Noyes, Electromechanical impactor for producing experimental spinal cord injury in animals, Med Biol Eng Comput, vol.25, issue.3, pp.335-375, 1987.
DOI : 10.1007/bf02447434

B. T. Stokes, D. H. Noyes, and D. L. Behrmann, An electromechanical spinal injury technique with dynamic sensitivity, J Neurotrauma, vol.9, issue.3, pp.187-95, 1992.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 140

J. C. Bresnahan, Three-dimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat, J Neurotrauma, vol.8, issue.2, pp.91-101, 1991.

G. Guizar-sahagun, Development of post-traumatic cysts in the spinal cord of ratssubjected to severe spinal cord contusion, Surg Neurol, vol.41, issue.3, pp.241-250, 1994.

T. E. Anderson and B. T. Stokes, Experimental models for spinal cord injury research: physical and physiological considerations, J Neurotrauma, issue.9, pp.135-177, 1992.

D. L. Behrmann, J. C. Bresnahan, and M. S. Beattie, Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673, Exp Neurol, vol.126, issue.1, pp.61-75, 1994.

R. Talac, Animal models of spinal cord injury for evaluation of tissue engineering treatment strategies, Biomaterials, vol.25, issue.9, pp.1505-1515, 2004.

G. D. Carlson and C. Gorden, Current developments in spinal cord injury research, Spine J, vol.2, issue.2, pp.116-144, 2002.
DOI : 10.1016/s1529-9430(01)00029-8

A. , A. R. Surgery, and O. Column, A PRELIMINARY REPORT. Journal of the American Medical Association, issue.11, pp.878-880, 1911.

N. K. Liu, A novel role of phospholipase A2 in mediating spinal cord secondary injury, Ann Neurol, vol.59, issue.4, pp.606-625, 2006.

N. Zhang, Inflammation & apoptosis in spinal cord injury, Indian J Med Res, vol.135, pp.287-96, 2012.

C. H. Tator, Update on the pathophysiology and pathology of acute spinal cord injury, Brain Pathol, vol.5, issue.4, pp.407-420, 1995.

G. J. Dohrmann, F. C. Wagner, J. , and P. C. Bucy, The microvasculature in transitory traumatic paraplegia. An electron microscopic study in the monkey, J Neurosurg, vol.35, issue.3, pp.263-71, 1971.
DOI : 10.3171/jns.1971.35.3.0263

C. H. Tator and I. Koyanagi, Vascular mechanisms in the pathophysiology of human spinal cord injury, J Neurosurg, vol.86, issue.3, pp.483-92, 1997.

J. W. Rowland, Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon, Neurosurg Focus, vol.25, issue.5, p.2, 2008.

A. Sakamoto, Relationship between free radical production and lipid peroxidation during ischemia-reperfusion injury in the rat brain, Brain Res, vol.554, issue.1-2, pp.186-92, 1991.
DOI : 10.1016/0006-8993(91)90187-z

E. Park, A. A. Velumian, and M. G. Fehlings, The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration, J Neurotrauma, vol.21, issue.6, pp.754-74, 2004.

M. J. Crowe, Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys, Nat Med, vol.3, issue.1, pp.73-79, 1997.

D. J. Donnelly and P. G. Popovich, Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury, Exp Neurol, vol.209, issue.2, pp.378-88, 2008.

C. E. Hill, M. S. Beattie, and J. C. Bresnahan, Degeneration and sprouting of identified descending supraspinal axons after contusive spinal cord injury in the rat, Exp Neurol, vol.171, issue.1, pp.153-69, 2001.

W. F. Windle and W. W. Chambers, Regeneration in the spinal cord of the cat and dog, AMA Arch Neurol Psychiatry, vol.65, issue.2, pp.261-263, 1951.

M. T. Fitch and J. Silver, CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure, Exp Neurol, vol.209, issue.2, pp.294-301, 2008.

M. T. Fitch and J. Silver, Glial cell extracellular matrix: boundaries for axon growth in development and regeneration, Cell Tissue Res, vol.290, issue.2, pp.379-84, 1997.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 141

T. Becker, Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury, Glia, vol.29, issue.4, pp.330-376, 2000.

I. Apostolova, A. Irintchev, and M. Schachner, Tenascin-R restricts posttraumatic remodeling of motoneuron innervation and functional recovery after spinal cord injury in adult mice, J Neurosci, vol.26, issue.30, pp.7849-59, 2006.

G. Yiu and Z. He, Glial inhibition of CNS axon regeneration, Nat Rev Neurosci, vol.7, issue.8, pp.617-644, 2006.

P. J. Horner and F. H. Gage, Regenerating the damaged central nervous system, Nature, vol.407, issue.6807, pp.963-70, 2000.

H. S. Chhabra and K. Sarda, Stem cell therapy in spinal trauma: Does it have scientific validity?, Indian J Orthop, vol.49, issue.1, pp.56-71, 2015.

N. Nagoshi and M. G. Fehlings, Investigational drugs for the treatment of spinal cord injury: review of preclinical studies and evaluation of clinical trials from Phase I to II, Expert Opin Investig Drugs, vol.24, issue.5, pp.645-58, 2015.

R. A. Grant, J. L. Quon, and K. M. Abbed, Management of acute traumatic spinal cord injury, Curr Treat Options Neurol, vol.17, issue.2, p.334, 2015.

R. Labruyere, A. Agarwala, and A. Curt, Rehabilitation in spine and spinal cord trauma. Spine (Phila Pa 1976), pp.259-62, 1921.

L. M. Ramer, M. S. Ramer, and E. J. Bradbury, Restoring function after spinal cord injury: towards clinical translation of experimental strategies, Lancet Neurol, vol.13, issue.12, pp.1241-56, 2014.

M. G. Fehlings, J. R. Wilson, and N. Cho, Methylprednisolone for the treatment of acute spinal cord injury: counterpoint. Neurosurgery, vol.61, pp.36-42, 2014.

M. B. Bracken, Efficacy of methylprednisolone in acute spinal cord injury, Jama, vol.251, issue.1, pp.45-52, 1984.

M. B. Bracken, Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study, J Neurosurg, vol.63, issue.5, pp.704-717, 1985.

M. B. Bracken, A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study, N Engl J Med, vol.322, pp.1405-1416, 1920.

M. B. Bracken, Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study, Jama, vol.277, pp.1597-604, 1920.

R. J. Hurlbert, Methylprednisolone for the treatment of acute spinal cord injury: point. Neurosurgery, vol.61, pp.32-37, 2014.

S. R. White, G. K. Crane, and D. A. Jackson, Thyrotropin-releasing hormone (TRH) effects on spinal cord neuronal excitability, Ann N Y Acad Sci, vol.553, pp.337-50, 1989.

L. H. Pitts, Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries, J Neurotrauma, vol.12, issue.3, pp.235-278, 1995.

D. D. Cardenas, Phase 2 trial of sustained-release fampridine in chronic spinal cord injury. Spinal Cord, vol.45, pp.158-68, 2007.

D. D. Cardenas, Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury, Spinal Cord, vol.52, issue.1, pp.70-76, 2014.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 142

B. K. Kwon, Magnesium chloride in a polyethylene glycol formulation as a neuroprotective therapy for acute spinal cord injury: preclinical refinement and optimization, J Neurotrauma, vol.26, issue.8, pp.1379-93, 2009.

H. M. Gransee, Localized delivery of brain-derived neurotrophic factor-expressing mesenchymal stem cells enhances functional recovery following cervical spinal cord injury, J Neurotrauma, vol.32, issue.3, pp.185-93, 2015.

I. Ullah, R. Subbarao, and G. Rho, Human mesenchymal stem cells-current trends and future prospective, Biosci Rep, 2015.

V. R. Dasari, K. K. Veeravalli, and D. H. Dinh, Mesenchymal stem cells in the treatment of spinal cord injuries: A review, World J Stem Cells, vol.6, issue.2, pp.120-153, 2014.

K. S. Straley, C. W. Foo, and S. C. Heilshorn, Biomaterial design strategies for the treatment of spinal cord injuries, J Neurotrauma, vol.27, issue.1, pp.1-19, 2010.

J. Widenfalk, Neurotrophic factors and receptors in the immature and adult spinal cord after mechanical injury or kainic acid, J Neurosci, vol.21, issue.10, pp.3457-75, 2001.

L. Schnell, Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion, Nature, vol.367, issue.6459, pp.170-173, 1994.

M. Shibayama, Neurotrophin-3 prevents death of axotomized Clarke's nucleus neurons in adult rat, J Comp Neurol, vol.390, issue.1, pp.102-113, 1998.

J. V. Coumans, Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins, J Neurosci, vol.21, issue.23, pp.9334-9378, 2001.

J. P. Merlio, Increased production of the TrkB protein tyrosine kinase receptor after brain insults, Neuron, vol.10, issue.2, pp.151-64, 1993.

N. Weishaupt, A. Blesch, and K. Fouad, BDNF: the career of a multifaceted neurotrophin in spinal cord injury, Exp Neurol, vol.238, issue.2, pp.254-64, 2012.

B. S. Bregman, Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat, Exp Neurol, vol.148, issue.2, pp.475-94, 1997.

L. N. Novikova, L. N. Novikov, and J. O. Kellerth, Differential effects of neurotrophins on neuronal survival and axonal regeneration after spinal cord injury in adult rats, J Comp Neurol, vol.452, issue.3, pp.255-63, 2002.

J. H. Ye and J. D. Houle, Treatment of the chronically injured spinal cord with neurotrophic factors can promote axonal regeneration from supraspinal neurons, Exp Neurol, vol.143, issue.1, pp.70-81, 1997.

M. Koda, Adenovirus vector-mediated in vivo gene transfer of brain-derived neurotrophic factor (BDNF) promotes rubrospinal axonal regeneration and functional recovery after complete transection of the adult rat spinal cord, J Neurotrauma, vol.21, issue.3, pp.329-366, 2004.

P. Lu, L. L. Jones, and M. H. Tuszynski, BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury, Exp Neurol, vol.191, issue.2, pp.344-60, 2005.

J. V. Lynskey, Delayed intervention with transplants and neurotrophic factors supports recovery of forelimb function after cervical spinal cord injury in adult rats, J Neurotrauma, vol.23, issue.5, pp.617-651, 2006.

A. Acheson, A BDNF autocrine loop in adult sensory neurons prevents cell death, Nature, vol.374, issue.6521, pp.450-453, 1995.

L. N. Novikova, L. N. Novikov, and J. O. Kellerth, Survival effects of BDNF and NT-3 on axotomized rubrospinal neurons depend on the temporal pattern of neurotrophin administration, Eur J Neurosci, vol.12, issue.2, pp.776-80, 2000.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 143

N. R. Kobayashi, BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration, J Neurosci, vol.17, issue.24, pp.9583-95, 1997.

K. M. Giehl and W. Tetzlaff, BDNF and NT-3, but not NGF, prevent axotomy-induced death of rat corticospinal neurons in vivo, Eur J Neurosci, vol.8, issue.6, pp.1167-75, 1996.

M. Sasaki, BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury, J Neurosci, vol.29, issue.47, pp.14932-14973, 2009.

N. M. Geremia, Endogenous BDNF regulates induction of intrinsic neuronal growth programs in injured sensory neurons, Exp Neurol, vol.223, issue.1, pp.128-170, 2010.

Y. Gao, Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase, J Neurosci, vol.23, issue.37, pp.11770-11777, 2003.

T. Gordon, The role of neurotrophic factors in nerve regeneration, Neurosurg Focus, vol.26, issue.2, p.3, 2009.

D. Cai, Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism, Neuron, vol.22, issue.1, pp.89-101, 1999.

A. Blesch, Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects, Exp Neurol, vol.235, issue.1, pp.162-73, 2012.

K. Fouad and A. Tse, Adaptive changes in the injured spinal cord and their role in promoting functional recovery, Neurol Res, vol.30, issue.1, pp.17-27, 2008.

G. W. Hiebert, Brain-derived neurotrophic factor applied to the motor cortex promotes sprouting of corticospinal fibers but not regeneration into a peripheral nerve transplant, J Neurosci Res, vol.69, issue.2, pp.160-168, 2002.

R. Vavrek, BDNF promotes connections of corticospinal neurons onto spared descending interneurons in spinal cord injured rats, Brain, issue.129, pp.1534-1579, 2006.

K. Fouad, R. Vavrek, and S. Cho, A TrkB antibody agonist promotes plasticity following cervical spinal cord injury in adult rats, J Neurotrauma, 2010.

L. T. Alto, Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury, Nat Neurosci, vol.12, issue.9, pp.1106-1119, 2009.

B. K. Kwon, Pathophysiology and pharmacologic treatment of acute spinal cord injury, Spine J, vol.4, issue.4, pp.451-64, 2004.

D. M. Mctigue, Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord, J Neurosci, vol.18, issue.14, pp.5354-65, 1998.

M. Koda, Brain-derived neurotrophic factor suppresses delayed apoptosis of oligodendrocytes after spinal cord injury in rats, J Neurotrauma, vol.19, issue.6, pp.777-85, 2002.

C. Girard, Grafts of brain-derived neurotrophic factor and neurotrophin 3-transduced primate Schwann cells lead to functional recovery of the demyelinated mouse spinal cord, J Neurosci, vol.25, issue.35, pp.7924-7957, 2005.

T. Hagg and M. Oudega, Degenerative and spontaneous regenerative processes after spinal cord injury, J Neurotrauma, vol.23, pp.264-80, 2006.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 144

H. S. Sharma, Brain derived neurotrophic factor and insulin like growth factor-1 attenuate upregulation of nitric oxide synthase and cell injury following trauma to the spinal cord. An immunohistochemical study in the rat, Amino Acids, vol.14, issue.1-3, pp.121-130, 1998.

E. A. Joosten and D. A. Houweling, Local acute application of BDNF in the lesioned spinal cord anti-inflammatory and anti-oxidant effects, Neuroreport, vol.15, issue.7, pp.1163-1169, 2004.

Y. Jiang, Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat, Mediators Inflamm, p.372423, 2010.

I. Wong, ProBDNF inhibits infiltration of ED1+ macrophages after spinal cord injury, Brain Behav Immun, vol.24, issue.4, pp.585-97, 2010.

M. Oudega and T. Hagg, Neurotrophins promote regeneration of sensory axons in the adult rat spinal cord, Brain Res, vol.818, issue.2, pp.431-439, 1999.

L. B. Jakeman, Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury, Exp Neurol, vol.154, issue.1, pp.170-84, 1998.

F. Dittrich, Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons, Exp Neurol, vol.141, issue.2, pp.225-264, 1996.

Y. Liu, Transplants of fibroblasts genetically modified to express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function, J Neurosci, vol.19, issue.11, pp.4370-87, 1999.

E. J. Bradbury, NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord, Eur J Neurosci, vol.11, issue.11, pp.3873-83, 1999.

M. S. Ramer, J. V. Priestley, and S. B. Mcmahon, Functional regeneration of sensory axons into the adult spinal cord, Nature, vol.403, issue.6767, pp.312-318, 2000.

C. Lima, Olfactory mucosa autografts in human spinal cord injury: a pilot clinical study, J Spinal Cord Med, vol.29, issue.3, pp.204-210, 2006.

F. Feron, Autologous olfactory ensheathing cell transplantation in human spinal cord injury, Brain, issue.128, pp.2951-60, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00093227

P. Tabakow, Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury, Cell Transplant, vol.22, issue.9, pp.1591-612, 2013.

N. Knoller, Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results, J Neurosurg Spine, vol.3, issue.3, pp.173-81, 2005.

D. P. Lammertse, Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial, Spinal Cord, vol.50, issue.9, pp.661-71, 2012.

N. Uchida, Direct isolation of human central nervous system stem cells, Proc Natl Acad Sci, vol.97, issue.26, pp.14720-14725, 2000.

H. Saberi, Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes, Neurosci Lett, vol.443, issue.1, pp.46-50, 2008.

H. Saberi, Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases, J Neurosurg Spine, vol.15, issue.5, pp.515-540, 2011.

K. Takahashi and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, vol.126, issue.4, pp.663-76, 2006.

K. Takahashi, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, issue.5, pp.861-72, 2007.

O. Tsuji, Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury, Proc Natl Acad Sci, vol.107, issue.28, pp.12704-12713, 2010.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 145

S. Nori, Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice, Proc Natl Acad Sci, vol.108, issue.40, pp.16825-16855, 2011.

D. D. Pearse and M. B. Bunge, Designing cell-and gene-based regeneration strategies to repair the injured spinal cord, J Neurotrauma, vol.23, pp.438-52, 2006.

A. I. Caplan, Why are MSCs therapeutic? New data: new insight, J Pathol, vol.217, issue.2, pp.318-342, 2009.

G. J. Delcroix, Adult cell therapy for brain neuronal damages and the role of tissue engineering, Biomaterials, vol.31, issue.8, pp.2105-2125, 2010.

G. J. Delcroix, EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells. Differentiation, vol.80, pp.213-240, 2010.

J. Li and G. Lepski, Cell transplantation for spinal cord injury: a systematic review, Biomed Res Int, p.786475, 2013.

M. M. Lalu, Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials, PLoS One, vol.7, issue.10, p.47559, 2012.

J. S. Park, Engineering mesenchymal stem cells for regenerative medicine and drug delivery, Methods, vol.84, pp.3-16, 2015.

A. Uccelli, Neuroprotective features of mesenchymal stem cells, Best Pract Res Clin Haematol, vol.24, issue.1, pp.59-64, 2011.

A. Bartholomew, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp Hematol, vol.30, issue.1, pp.42-50, 2002.

D. Nicola and M. , Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, vol.99, issue.10, pp.3838-3881, 2002.

B. Neuhuber, Axon growth and recovery of function supported by human bone marrow stromal cells in the injured spinal cord exhibit donor variations, Brain Res, vol.1035, issue.1, pp.73-85, 2005.

B. T. Himes, Recovery of function following grafting of human bone marrow-derived stromal cells into the injured spinal cord, Neurorehabil Neural Repair, vol.20, issue.2, pp.278-96, 2006.

M. B. Abrams, Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury, Restor Neurol Neurosci, vol.27, issue.4, pp.307-328, 2009.

C. P. Hofstetter, Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery, Proc Natl Acad Sci, vol.99, issue.4, pp.2199-204, 2002.

K. T. Wright, Concise review: Bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications, Stem Cells, vol.29, issue.2, pp.169-78, 2011.

L. N. Novikova, Neuroprotective and growth-promoting effects of bone marrow stromal cells after cervical spinal cord injury in adult rats, Cytotherapy, vol.13, issue.7, pp.873-87, 2011.

Y. B. Deng, Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys, Cytotherapy, vol.8, issue.3, pp.210-214, 2006.

M. Zurita, Functional recovery of chronic paraplegic pigs after autologous transplantation of bone marrow stromal cells, Transplantation, vol.86, issue.6, pp.845-53, 2008.

E. Sykova, Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair, Cell Mol Neurobiol, vol.26, pp.1113-1142, 2006.

E. Sykova, Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury, Cell Transplant, vol.15, pp.675-87, 2006.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 146

S. H. Yoon, Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial, Stem Cells, vol.25, issue.8, pp.2066-73, 2007.

M. V. Mendonca, Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury, Stem Cell Res Ther, vol.5, issue.6, p.126, 2014.

D. G. Phinney, Donor variation in the growth properties and osteogenic potential of human marrow stromal cells, J Cell Biochem, vol.75, issue.3, pp.424-460, 1999.

A. D. Ho, W. Wagner, and W. Franke, Heterogeneity of mesenchymal stromal cell preparations, Cytotherapy, vol.10, issue.4, pp.320-350, 2008.

D. Ippolito and G. , Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential, 2004.

S. Roche, Comparative analysis of protein expression of three stem cell populations: models of cytokine delivery system in vivo, Int J Pharm, vol.440, issue.1, pp.72-82, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00802595

V. M. Tatard, Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons, Bone, vol.40, issue.2, pp.360-73, 2007.

S. Gronthos, Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo, Proc Natl Acad Sci, vol.97, issue.25, pp.13625-13655, 2000.

S. Shi, P. G. Robey, and S. Gronthos, Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis, Bone, vol.29, issue.6, pp.532-541, 2001.

J. Bianco, Taking a bite out of spinal cord injury: do dental stem cells have the teeth for it?, Cell Mol Life Sci, vol.73, issue.7, pp.1413-1450, 2016.

P. C. Demircan, Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems, Cytotherapy, vol.13, issue.10, pp.1205-1225, 2011.

M. Hamanoue, Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro, J Neurosci Res, vol.43, issue.5, pp.554-64, 1996.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 147

A. Ebens, Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons, Neuron, vol.17, issue.6, pp.1157-72, 1996.

K. Kitamura, Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury, J Neurosci Res, vol.85, issue.11, pp.2332-2374, 2007.

N. Ferrara, Molecular and biological properties of vascular endothelial growth factor, J Mol Med, issue.7, pp.527-570

Z. Zhang and L. Guth, Experimental spinal cord injury: Wallerian degeneration in the dorsal column is followed by revascularization, glial proliferation, and nerve regeneration, Exp Neurol, vol.147, issue.1, pp.159-71, 1997.

G. T. Casella, New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord, Exp Neurol, vol.173, issue.1, pp.63-76, 2002.

K. Jin, Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo, Proc Natl Acad Sci, vol.99, issue.18, pp.11946-50, 2002.

J. Pelletier, VEGF-A promotes both pro-angiogenic and neurotrophic capacities for nerve recovery after compressive neuropathy in rats, Mol Neurobiol, vol.51, issue.1, pp.240-51, 2015.

L. Jiang, The expression and role of stromal cell-derived factor-1alpha-CXCR4 axis in human dental pulp, J Endod, vol.34, issue.8, pp.939-983, 2008.

Y. Akazawa, Recruitment of mesenchymal stem cells by stromal cell-derived factor 1alpha in pulp cells from deciduous teeth, Int J Mol Med, vol.36, issue.2, pp.442-450, 2015.

A. Jaerve, F. Bosse, and H. W. Muller, SDF-1/CXCL12: its role in spinal cord injury, Int J Biochem Cell Biol, vol.44, issue.3, pp.452-458, 2012.

J. Opatz, SDF-1 stimulates neurite growth on inhibitory CNS myelin, Mol Cell Neurosci, vol.40, issue.2, pp.293-300, 2009.

W. C. Shyu, Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats, J Pharmacol Exp Ther, vol.324, issue.2, pp.834-883, 2008.

A. R. Calver, Oligodendrocyte population dynamics and the role of PDGF in vivo, Neuron, vol.20, issue.5, pp.869-82, 1998.

J. G. Hu, Platelet-derived growth factor-AA mediates oligodendrocyte lineage differentiation through activation of extracellular signal-regulated kinase signaling pathway, Neuroscience, vol.151, issue.1, pp.138-185, 2008.

K. A. Derringer and R. W. Linden, Vascular endothelial growth factor, fibroblast growth factor 2, platelet derived growth factor and transforming growth factor beta released in human dental pulp following orthodontic force, Arch Oral Biol, vol.49, issue.8, pp.631-672, 2004.

L. Tran-hung, Quantification of angiogenic growth factors released by human dental cells after injury, Arch Oral Biol, vol.53, issue.1, pp.9-13, 2008.

K. Janebodin, Isolation and characterization of neural crest-derived stem cells from dental pulp of neonatal mice, PLoS One, vol.6, issue.11, p.27526, 2011.

E. J. Huang and L. F. Reichardt, Neurotrophins: roles in neuronal development and function, Annu Rev Neurosci, vol.24, pp.677-736, 2001.

F. M. De-almeida, Human dental pulp cells: a new source of cell therapy in a mouse model of compressive spinal cord injury, J Neurotrauma, vol.28, issue.9, pp.1939-1988, 2011.

B. Mead, Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury, Invest Ophthalmol Vis Sci, vol.54, issue.12, pp.7544-56, 2013.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 148

B. Mead, Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells, PLoS One, vol.9, issue.10, p.109305, 2014.

I. V. Nosrat, Dental pulp cells produce neurotrophic factors, interact with trigeminal neurons in vitro, and rescue motoneurons after spinal cord injury, Dev Biol, vol.238, issue.1, pp.120-152, 2001.

I. V. Nosrat, Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system, Eur J Neurosci, vol.19, issue.9, pp.2388-98, 2004.

K. Sakai, Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms, J Clin Invest, vol.122, issue.1, pp.80-90, 2012.

A. Yamamoto, Multifaceted neuro-regenerative activities of human dental pulp stem cells for functional recovery after spinal cord injury, Neurosci Res, vol.78, pp.16-20, 2014.

W. Martens, Dental stem cells and their promising role in neural regeneration: an update, Clin Oral Investig, vol.17, issue.9, pp.1969-83, 2013.

J. F. De-almeida, Stem cells of the apical papilla regulate trigeminal neurite outgrowth and targeting through a BDNF-dependent mechanism, Tissue Eng Part A, vol.20, pp.3089-100, 2014.

G. Ding, Effect of cryopreservation on biological and immunological properties of stem cells from apical papilla, J Cell Physiol, vol.223, issue.2, pp.415-437, 2010.

A. Bakopoulou, Angiogenic Potential and Secretome of Human Apical Papilla Mesenchymal Stem Cells in Various Stress Microenvironments, Stem Cells Dev, vol.24, issue.21, pp.2496-512, 2015.

P. De-berdt, Dental Apical Papilla as Therapy for Spinal Cord Injury, J Dent Res, vol.94, issue.11, pp.1575-81, 2015.

L. A. Smith, X. Liu, and P. X. Ma, Tissue engineering with nano-fibrous scaffolds, 2008.

F. J. O'brien, Biomaterials & scaffolds for tissue engineering, Materials Today, vol.14, issue.3, pp.88-95, 2011.

P. Lu, Long-distance growth and connectivity of neural stem cells after severe spinal cord injury, Cell, vol.150, issue.6, pp.1264-73, 2012.

R. E. Gamez-sazo, Fabrication of growth factor-and extracellular matrix-loaded, gelatinbased scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia, Biomaterials, vol.33, issue.33, pp.8529-8568, 2012.

M. Madaghiele, Collagen-based matrices with axially oriented pores, J Biomed Mater Res A, vol.85, issue.3, pp.757-67, 2008.
DOI : 10.1002/jbm.a.31517

N. N. Madigan, Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds, Respir Physiol Neurobiol, vol.169, issue.2, pp.183-99, 2009.
DOI : 10.1016/j.resp.2009.08.015
URL : http://europepmc.org/articles/pmc2981799?pdf=render

Q. Han, The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody, Biomaterials, vol.31, issue.35, pp.9212-9232, 2010.

M. H. Spilker, The effects of tubulation on healing and scar formation after transection of the adult rat spinal cord, Restor Neurol Neurosci, vol.18, issue.1, pp.23-38, 2001.

S. Yoshii, Functional restoration of rabbit spinal cord using collagen-filament scaffold, J Tissue Eng Regen Med, vol.3, issue.1, pp.19-25, 2009.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 149

T. A. Ahmed, E. V. Dare, and M. Hincke, Fibrin: a versatile scaffold for tissue engineering applications, Tissue Eng Part B Rev, vol.14, issue.2, pp.199-215, 2008.
DOI : 10.1089/teb.2007.0435

P. J. Johnson, S. R. Parker, and S. E. Sakiyama-elbert, Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury, Biotechnol Bioeng, vol.104, issue.6, pp.1207-1221, 2009.
DOI : 10.1002/bit.22476
URL : http://europepmc.org/articles/pmc2780336?pdf=render

V. R. King, Characterization of non-neuronal elements within fibronectin mats implanted into the damaged adult rat spinal cord, Biomaterials, vol.27, issue.3, pp.485-96, 2006.

V. R. King, The use of injectable forms of fibrin and fibronectin to support axonal ingrowth after spinal cord injury, Biomaterials, vol.31, issue.15, pp.4447-56, 2010.

Z. Z. Khaing, High molecular weight hyaluronic acid limits astrocyte activation and scar formation after spinal cord injury, J Neural Eng, vol.8, issue.4, p.46033, 2011.
DOI : 10.1088/1741-2560/8/4/046033

Y. T. Wei, Hyaluronic acid hydrogel modified with nogo-66 receptor antibody and poly-Llysine to promote axon regrowth after spinal cord injury, J Biomed Mater Res B Appl Biomater, vol.95, issue.1, pp.110-117, 2010.
DOI : 10.1002/jbm.b.31689

J. Park, Nerve regeneration following spinal cord injury using matrix metalloproteinasesensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor, J Biomed Mater Res A, vol.93, issue.3, pp.1091-1100, 2010.
DOI : 10.1002/jbm.a.32519

M. Gao, Templated agarose scaffolds for the support of motor axon regeneration into sites of complete spinal cord transection, Biomaterials, vol.34, issue.5, pp.1529-1565, 2013.

S. Stokols and M. H. Tuszynski, Freeze-dried agarose scaffolds with uniaxial channels stimulate and guide linear axonal growth following spinal cord injury, Biomaterials, vol.27, issue.3, pp.443-51, 2006.
DOI : 10.1016/j.biomaterials.2005.06.039

G. Vaissiere, Comparative analysis of different collagen-based biomaterials as scaffolds for long-term culture of human fibroblasts, Med Biol Eng Comput, vol.38, issue.2, pp.205-215, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00313316

Y. D. Teng, Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells, Proc Natl Acad Sci, vol.99, issue.5, pp.3024-3033, 2002.

M. J. Moore, Multiple-channel scaffolds to promote spinal cord axon regeneration, Biomaterials, vol.27, issue.3, pp.419-448, 2006.

H. E. Olson, Neural stem cell-and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord, Tissue Eng Part A, vol.15, issue.7, pp.1797-805, 2009.

K. N. Kang, Regeneration of completely transected spinal cord using scaffold of poly(D,Llactide-co-glycolide)/small intestinal submucosa seeded with rat bone marrow stem cells, Tissue Eng Part A, pp.2143-52, 2011.

H. Nomura, Extramedullary chitosan channels promote survival of transplanted neural stem and progenitor cells and create a tissue bridge after complete spinal cord transection, Tissue Eng Part A, vol.14, issue.5, pp.649-65, 2008.

C. T. Montgomery, E. A. Tenaglia, and J. A. Robson, Axonal growth into tubes implanted within lesions in the spinal cords of adult rats, Exp Neurol, vol.137, issue.2, pp.277-90, 1996.

H. Nomura, Complete spinal cord transection treated by implantation of a reinforced synthetic hydrogel channel results in syringomyelia and caudal migration of the rostral stump, Neurosurgery, vol.59, issue.1, pp.183-92, 2006.

M. Tsintou, K. Dalamagkas, and A. M. Seifalian, Advances in regenerative therapies for spinal cord injury: a biomaterials approach, Neural Regen Res, vol.10, issue.5, pp.726-768, 2015.

A. J. Mothe, Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel, Biomaterials, vol.34, issue.15, pp.3775-83, 2013.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 150

P. J. Johnson, Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI, Cell Transplant, vol.19, issue.1, pp.89-101, 2010.

G. E. Rooney, Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels, Tissue Eng Part A, vol.17, issue.9, pp.1287-302, 2011.

V. M. Tatard, Pharmacologically active microcarriers releasing glial cell line-derived neurotrophic factor: Survival and differentiation of embryonic dopaminergic neurons after grafting in hemiparkinsonian rats, Biomaterials, vol.28, issue.11, pp.1978-88, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00258197

V. M. Tatard, Pharmacologically active microcarriers: a tool for cell therapy, Biomaterials, vol.26, issue.17, pp.3727-3764, 2005.

C. Penna, Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival, J Cell Mol Med, vol.17, issue.1, pp.192-204, 2013.

C. Musilli, Pharmacologically active microcarriers for endothelial progenitor cell support and survival, Eur J Pharm Biopharm, vol.81, issue.3, pp.609-625, 2012.

D. K. Binder and H. E. Scharfman, Brain-derived neurotrophic factor, Growth Factors, vol.22, issue.3, pp.123-154, 2004.

T. Zigova, Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb, Mol Cell Neurosci, vol.11, issue.4, pp.234-279, 1998.

A. Benraiss, Adenoviral brain-derived neurotrophic factor induces both neostriatal and olfactory neuronal recruitment from endogenous progenitor cells in the adult forebrain, J Neurosci, vol.21, issue.17, pp.6718-6749, 2001.

K. D. Dougherty, C. F. Dreyfus, and I. B. Black, Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury, Neurobiol Dis, issue.7, pp.574-85, 2000.

A. Giteau, Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres, Eur J Pharm Biopharm, vol.70, issue.1, pp.127-163, 2008.

C. Merceron, The effect of two-and three-dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel, Cell Transplant, vol.20, issue.10, pp.1575-88, 2011.

C. Vinatier, A silanized hydroxypropyl methylcellulose hydrogel for the three-dimensional culture of chondrocytes, Biomaterials, vol.26, issue.33, pp.6643-51, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00110465

X. Struillou, The association of hydrogel and biphasic calcium phosphate in the treatment of dehiscence-type peri-implant defects: an experimental study in dogs, J Mater Sci Mater Med, vol.24, issue.12, pp.2749-60, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-01848060

V. M. Tatard, Combining polymeric devices and stem cells for the treatment of neurological disorders: a promising therapeutic approach, Curr Drug Targets, vol.6, issue.1, pp.81-96, 2005.

J. P. Bertram, Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF, Pharm Res, vol.27, issue.1, pp.82-91, 2010.

I. J. Castellanos, G. Flores, and K. Griebenow, Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation, J Pharm Sci, vol.95, issue.4, pp.849-58, 2006.

W. Swietnicki, pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231), J Biol Chem, vol.272, issue.44, pp.27517-27537, 1997.

B. Bittner, Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media REFERENCES Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI, p.151

, on polymer erosion and bovine serum albumin release, J Control Release, vol.60, issue.2-3, pp.297-309, 1999.

A. Aubert-pouessel, In vitro study of GDNF release from biodegradable PLGA microspheres, J Control Release, vol.95, issue.3, pp.463-75, 2004.

D. Drago, The stem cell secretome and its role in brain repair, Biochimie, vol.95, issue.12, pp.2271-85, 2013.

A. H. Nagahara and M. H. Tuszynski, Potential therapeutic uses of BDNF in neurological and psychiatric disorders, Nat Rev Drug Discov, vol.10, issue.3, pp.209-228, 2011.

A. E. Autry and L. M. Monteggia, Brain-derived neurotrophic factor and neuropsychiatric disorders, Pharmacol Rev, vol.64, issue.2, pp.238-58, 2012.

S. Balaratnasingam and A. Janca, Brain Derived Neurotrophic Factor: a novel neurotrophin involved in psychiatric and neurological disorders, Pharmacol Ther, vol.134, issue.1, pp.116-140, 2012.

C. Zuccato and E. Cattaneo, Role of brain-derived neurotrophic factor in Huntington's disease, Prog Neurobiol, vol.81, pp.294-330, 2007.

C. Zuccato and E. Cattaneo, Brain-derived neurotrophic factor in neurodegenerative diseases, Nat Rev Neurol, vol.5, issue.6, pp.311-333, 2009.

A. H. Nagahara, Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease, Nat Med, vol.15, issue.3, pp.331-338, 2009.

C. Giampa, Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6/2 mouse model of Huntington's disease, PLoS One, vol.8, issue.5, p.64037, 2013.

A. Giralt, Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction, Mol Neurodegener, vol.6, issue.1, p.71, 2011.

T. Tsukahara, Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine-induced parkinsonism in monkeys, Neurosurgery, vol.37, issue.4, pp.739-780, 1995.

, A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III), Neurology, vol.52, issue.7, pp.1427-1460, 1999.

B. A. Kakulas, Pathology of spinal injuries, Cent Nerv Syst Trauma, vol.1, issue.2, pp.117-146, 1984.

B. A. Kakulas, A review of the neuropathology of human spinal cord injury with emphasis on special features, J Spinal Cord Med, vol.22, issue.2, pp.119-143, 1999.

M. E. Schwab and D. Bartholdi, Degeneration and regeneration of axons in the lesioned spinal cord, Physiol Rev, vol.76, issue.2, pp.319-70, 1996.

O. Kiehn, Locomotor circuits in the mammalian spinal cord, Annu Rev Neurosci, vol.29, pp.279-306, 2006.

S. Rossignol, R. Dubuc, and J. P. Gossard, Dynamic sensorimotor interactions in locomotion, Physiol Rev, vol.86, issue.1, pp.89-154, 2006.

A. Ghosh, Functional and anatomical reorganization of the sensory-motor cortex after incomplete spinal cord injury in adult rats, J Neurosci, vol.29, issue.39, pp.12210-12219, 2009.

K. E. Tansey, Neural plasticity and locomotor recovery after spinal cord injury, Pm r, issue.2, pp.220-226, 2010.

S. Rossignol and A. Frigon, Recovery of locomotion after spinal cord injury: some facts and mechanisms, Annu Rev Neurosci, vol.34, pp.413-453, 2011.

A. L. Hawthorne, The unusual response of serotonergic neurons after CNS Injury: lack of axonal dieback and enhanced sprouting within the inhibitory environment of the glial scar, J Neurosci, vol.31, issue.15, pp.5605-5621, 2011.

B. Zorner, Chasing central nervous system plasticity: the brainstem's contribution to locomotor recovery in rats with spinal cord injury, Brain, issue.137, pp.1716-1748, 2014.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 152

M. Ghosh and D. D. Pearse, The role of the serotonergic system in locomotor recovery after spinal cord injury, Front Neural Circuits, vol.8, p.151, 2014.

X. Z. Liu, Neuronal and glial apoptosis after traumatic spinal cord injury, J Neurosci, vol.17, issue.14, pp.5395-406, 1997.

Q. Yan, The biological responses of axotomized adult motoneurons to brain-derived neurotrophic factor, J Neurosci, vol.14, issue.9, pp.5281-91, 1994.

Y. Iwashita, S. Kawaguchi, and M. Murata, Restoration of function by replacement of spinal cord segments in the rat, Nature, vol.367, issue.6459, pp.167-70, 1994.

A. Kishino, BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth, Exp Neurol, vol.144, issue.2, pp.273-86, 1997.

S. Kandalam, Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement, Acta Biomater, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01845036

D. M. Basso, M. S. Beattie, and J. C. Bresnahan, Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection, Exp Neurol, vol.139, issue.2, pp.244-56, 1996.

D. N. Loy, Functional redundancy of ventral spinal locomotor pathways, J Neurosci, vol.22, issue.1, pp.315-338, 2002.

X. M. Xu, A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord, Exp Neurol, vol.134, issue.2, pp.261-72, 1995.

U. Bilati, E. Allemann, and E. Doelker, Strategic approaches for overcoming peptide and protein instability within biodegradable nano-and microparticles, Eur J Pharm Biopharm, vol.59, issue.3, pp.375-88, 2005.

X. M. Lam, Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes, J Control Release, vol.67, issue.2-3, pp.281-92, 2000.

J. Wang, K. M. Chua, and C. H. Wang, Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres, J Colloid Interface Sci, vol.271, issue.1, pp.92-101, 2004.

T. Morita, Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly(ethylene glycol) aqueous mixture, Pharm Res, vol.17, issue.11, pp.1367-73, 2000.

R. A. Jain, Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables, Eur J Pharm Biopharm, vol.50, issue.2, pp.257-62, 2000.

T. Morita, Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant, J Control Release, vol.69, issue.3, pp.435-479, 2000.

T. Morita, Applicability of various amphiphilic polymers to the modification of protein release kinetics from biodegradable reservoir-type microspheres, Eur J Pharm Biopharm, vol.51, issue.1, pp.45-53, 2001.

A. Paillard-giteau, Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique, Eur J Pharm Biopharm, vol.75, issue.2, pp.128-164, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00626154

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 153

P. R. Foster, P. Dunnill, and M. D. Lilly, Salting-out of enzymes with ammonium sulphate, Biotechnol Bioeng, vol.13, issue.5, pp.713-721, 1971.

F. Rothstein, Differential precipitation of proteins. Science and technology, Bioprocess Technol, vol.18, pp.115-208, 1994.

T. Arakawa, Y. Kita, and J. F. Carpenter, Protein-solvent interactions in pharmaceutical formulations, Pharm Res, vol.8, issue.3, pp.285-91, 1991.

D. Mustafi, Multi-block poloxamer surfactants suppress aggregation of denatured proteins, Biochim Biophys Acta, vol.1780, issue.1, pp.7-15, 2008.

S. B. Cadichon, Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats, J Neurosurg, vol.106, issue.1, pp.36-40, 2007.

J. H. Gu, Poloxamer 188 protects neurons against ischemia/reperfusion injury through preserving integrity of cell membranes and blood brain barrier, PLoS One, vol.8, issue.4, p.61641, 2013.

S. Moein-moghimi, A. C. Christopher-m-dadswellb, S. Savayc, J. Carl-r-alvingc, and . Szebenic, Causative factors behind poloxamer 188 (Pluronic F68, Flocor?)-induced complement activation in human sera: A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels, vol.1689, pp.103-113, 2004.

V. Fabien, Development of prilling process for biodegradable microspheres through experimental designs, Int J Pharm, vol.498, issue.1-2, pp.96-109, 2016.

A. S. Determan, Protein stability in the presence of polymer degradation products: consequences for controlled release formulations, Biomaterials, vol.27, issue.17, pp.3312-3332, 2006.

K. Fu, A. M. Klibanov, and R. Langer, Protein stability in controlled-release systems, Nat Biotechnol, vol.18, issue.1, pp.24-29, 2000.

Y. Yeo and K. Park, Control of encapsulation efficiency and initial burst in polymeric microparticle systems, Arch Pharm Res, vol.27, issue.1, pp.1-12, 2004.

J. Siepmann, Effect of the size of biodegradable microparticles on drug release: experiment and theory, J Control Release, vol.96, issue.1, pp.123-157, 2004.

M. Morille, New PLGA-P188-PLGA matrix enhances TGF-?3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells, vol.170, pp.99-110, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00881128

Y. Akiyama, C. Radtke, and J. D. Kocsis, Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells, J Neurosci, vol.22, issue.15, pp.6623-6653, 2002.

G. C. Kopen, D. J. Prockop, and D. G. Phinney, Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains, Proc Natl Acad Sci, vol.96, pp.10711-10717, 1999.

D. Woodbury, Adult rat and human bone marrow stromal cells differentiate into neurons, J Neurosci Res, vol.61, issue.4, pp.364-70, 2000.

H. Nakajima, Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury, J Neurotrauma, vol.29, issue.8, pp.1614-1639, 2012.

E. Karaoz, Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation, Turk Neurosurg, vol.22, issue.2, pp.207-224, 2012.

W. B. Park, The effect of mesenchymal stem cell transplantation on the recovery of bladder and hindlimb function after spinal cord contusion in rats, BMC Neurosci, vol.11, p.119, 2010.

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI | | 154

M. S. Pedram, Transplantation of a combination of autologous neural differentiated and undifferentiated mesenchymal stem cells into injured spinal cord of rats, Spinal Cord, vol.48, issue.6, pp.457-63, 2010.

G. Munoz-elias, D. Woodbury, and I. B. Black, Marrow stromal cells, mitosis, and neuronal differentiation: stem cell and precursor functions, Stem Cells, vol.21, issue.4, pp.437-485, 2003.

M. Alvarez-dolado, Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes, Nature, vol.425, issue.6961, pp.968-73, 2003.

G. T. Huang, The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering, J Endod, vol.34, issue.6, pp.645-51, 2008.

G. T. Huang, S. Gronthos, and S. Shi, Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine, J Dent Res, vol.88, issue.9, pp.792-806, 2009.

G. Delcroix, C. K. Schiller, P. C. Montero-menei, and C. N. , EGF and bFGF pre-treatment enhances neural specification and the response to neuronal commitment of MIAMI cells, vol.80, pp.213-227, 2010.

W. H. Chen, Probing relevant molecules in modulating the neurite outgrowth of hippocampal neurons on substrates of different stiffness, PLoS One, vol.8, issue.12, p.83394, 2013.

R. Quertainmont, Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions, PLoS One, vol.7, issue.6, p.39500, 2012.

Y. Zhou, Expansion and delivery of adipose-derived mesenchymal stem cells on three microcarriers for soft tissue regeneration, Tissue Eng Part A, vol.17, pp.2981-97, 2011.

J. M. Fassbender, S. R. Whittemore, and T. Hagg, Targeting microvasculature for neuroprotection after SCI, Neurotherapeutics, vol.8, issue.2, pp.240-51, 2011.
DOI : 10.1007/s13311-011-0029-1
URL : https://link.springer.com/content/pdf/10.1007%2Fs13311-011-0029-1.pdf

I. A. Potapova, Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro, Stem Cells, vol.25, issue.7, pp.1761-1769, 2007.

T. Kinnaird, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, vol.94, issue.5, pp.678-85, 2004.

J. Niu, Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP), J Biol Chem, vol.283, issue.21, pp.14542-51, 2008.
DOI : 10.1074/jbc.m802139200
URL : http://www.jbc.org/content/283/21/14542.full.pdf

, Kandalam Saikrishna | PAMs delivering BDNF combined to MSCs for the treatment of SCI |

, Lakanal Hall of Residence, N-18, vol.25

H. , F. Uv-vis, F. , M. S. , X. et al., two years of industrial experience and certification in base SAS programming. COMPETENCES Personality: Leadership potential, Stress resistant (meet up with swift deadlines), self-planning and time management, dynamic team player, diplomatic interpersonal skills, public speaker, flexible and open mindset, problem solving approach, result oriented, matrix work environment and networking, mentor. Scientific skills: Pre-clinical research, Formulations-dosage form design with proteins, Stem cell cultures, Tissue engineering, GMP, Kinetic studies, toxicology, animal and cellular assays, immunochemistry, ELISA, RTqPCR, western blot, polymer applications, and advanced analytics

, Developing a controlled drug delivery system for therapeutic proteins using nanotechnology.-Culture and characterization of human mesenchymal stem cells, combined to 3D scaffolds for Brain or Spinal cord tissue engineering, Telugu (mother tongue), Hindi (Proficient user) PROFESSIONAL SUMMARY 2013-17 PhD research, Inserm U1066

). February-june and . Pédiatrique, Practical experience in technical operations, quality spec sheets.-Coordinated with the regulatory team and prepared documents related to Product Transfer Details (PTD) for Site transfer of the projects.-Prepared and reviewed In-process Specifications and SOPs, vitro and In vivo characterizations of liver stem cells with polymeric 3D scaffolds.-Networking with physicians, post docs and technicians. 2011-13 Quality Analyst-Aurobindo Pharma Ltd

. Ph,

, Major in Neuroscience, human mesenchymal stem cells, protein drug delivery and hydrogel 3D scaffolds for the treatment of spinal cord injury, pp.2013-2028

, Grade: First class (69.2%), Master's in Business Administration: Mahatma Gandhi University (India)

, Major in project management, international business, corporate strategies, stakeholder management, pp.2009-2020

, Master's in Pharmaceutical sciences-Andhra University (India), Grade: First class with distinction

, Major in Pharmacology and toxicology, Pharmacokinetic and drug metabolism, Bioassays and Biostatistics, pre-clinical & clinical research, analytical applications, pp.2005-2014

, Grade: First class (70%)

, Major in Pharmaceutical technology and formulation design, medicinal chemistry